| Neoadjuvant Immunotherapy in Locally Advanced Colon Cancers (NCT05833672) | fan li | 2023-05-01 |
| Cadonilimab in Combination With Chemotherapy for Locally Advaced Esophageal Squamous Cell Carcinoma (NCT05833971) | Guangzhou Institute of Respiratory Disease | 2023-05-01 |
| Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa (NCT05157958) | Anterogen Co., Ltd. | 2023-05-01 |
| Colostrum From MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial. (NCT06857318) | Hadassah Medical Organization | 2023-05-01 |
| Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer (NCT05799469) | Chongqing University Cancer Hospital | 2023-05-01 |
| Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis (NCT05973370) | Tanta University | 2023-05-01 |
| Efficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's Disease (NCT06694597) | Fujian Medical University Union Hospital | 2023-05-01 |
| Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial (NCT05764746) | Muhimbili University of Health and Allied Sciences | 2023-05-01 |
| Sequential AG and mFOLFOX Combined With Serplulimab Injection and Bevacizumab Injection in Untreated Advanced Pancreatic Cancer (NCT06393166) | Zhejiang Cancer Hospital | 2023-05-01 |
| The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma (NCT05827770) | Yong Chen | 2023-05-01 |
| Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female (NCT05329662) | Vinmec Research Institute of Stem Cell and Gene Technology | 2023-05-01 |
| Disitamab Vedotin Plus Cadonilimab in Patients With HER2 Mutant Advanced or Metastatic Bile Duct Adenocarcinoma (NCT06383533) | Zhejiang Cancer Hospital | 2023-05-01 |
| Saffron and Ulcerative Colitis (NCT05117749) | Shiraz University of Medical Sciences | 2023-05-01 |
| Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia (NCT05941156) | The Affiliated Hospital of Xuzhou Medical University | 2023-05-01 |
| The Effect of Post-extraction Collagen Sponge Application on Alveolar Osteitis (NCT05850650) | Riyadh Colleges of Dentistry and Pharmacy | 2023-05-01 |
| A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma (NCT05909527) | Guangzhou Bio-gene Technology Co., Ltd | 2023-05-01 |
| Combination of Chidamide and Fulvestrant for HR+/HER2- Breast Cancer That Has Failed Previous CDK4/6 i Adjuvant Therapy (NCT05806047) | Fudan University | 2023-05-01 |
| Electrical Neuromodulation for Focal Epilepsy (NCT05844696) | National Taiwan University Hospital | 2023-05-01 |
| A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis (NCT06332287) | Jiangsu Province Nanjing Brain Hospital | 2023-05-01 |
| Efficacy of Modified Fruquintinib in Colorectal Cancer Liver Metastases: A Phase II Study (NCT06018714) | Sun Yat-sen University | 2023-05-01 |
| Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease (NCT05870007) | Taipei Medical University Shuang Ho Hospital | 2023-05-01 |
| Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma (NCT05842746) | Peking Union Medical College Hospital | 2023-05-01 |
| Tiotropium Handihaler vs. Tiotropium Respimat in COPD (NCT05838703) | Duke University | 2023-05-01 |
| RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies (NCT05869669) | EIP Pharma Inc | 2023-05-01 |
| Allo HSCT Using RIC and PTCy for Hematological Diseases (NCT05805605) | Masonic Cancer Center, University of Minnesota | 2023-05-01 |
| Protecting Alzheimer Caregivers Using Technology Through Staying Sharp (NCT05260515) | Oregon Health and Science University | 2023-04-30 |
| CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases (NCT05827835) | Zhejiang University | 2023-04-30 |
| Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers (NCT05582031) | Translational Research in Oncology | 2023-04-30 |
| 18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer (NCT05815316) | IRCCS San Raffaele | 2023-04-30 |
| Lenvatinib for Advanced Bone and Soft Tissue Sarcoma (NCT05617859) | Henan Cancer Hospital | 2023-04-30 |
| Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene (NCT05529134) | Phoenicis Therapeutics | 2023-04-30 |
| The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train. (NCT05816694) | Peng Liu | 2023-04-30 |
| The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab (NCT05819060) | Fudan University | 2023-04-30 |
| Gemcitabine Plus S1 and Tislelizumab in the First Line Therapy of Advanced Biliary Tract Carcinoma (NCT05822453) | Peking Union Medical College Hospital | 2023-04-30 |
| Alcohol Use Disorder and Cannabidiol (NCT05613608) | University of Colorado, Denver | 2023-04-30 |
| Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus (NCT05688696) | Beijing InnoCare Pharma Tech Co., Ltd. | 2023-04-29 |
| Outcomes of High-volume Saline Irrigation VS Povidone-Iodine Solution Cleaning of IOWI in Preventing SSIs in Emergency Laparotomies (NCT05989386) | Dow University of Health Sciences | 2023-04-29 |
| Laparoscopic Guided Peri-wound Transversus Abdominis Plane Block With Bupivacaine Versus Local Wound Infiltration on Post-op Opioid Use in Laparoscopic Sleeve Gastrectomy (NCT05930184) | Khon Kaen University | 2023-04-29 |
| A Study of CM310 in Subjects With Moderate to Severe Asthma (NCT05761028) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2023-04-28 |
| Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers (NCT05641896) | SOFIE | 2023-04-28 |
| GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies (NCT05880043) | GI Cell, Inc. | 2023-04-28 |
| Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis (NCT05672199) | Amgen | 2023-04-28 |
| A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL (NCT05615636) | M.D. Anderson Cancer Center | 2023-04-28 |
| KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis (NCT05938725) | Kyverna Therapeutics | 2023-04-28 |
| A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors (NCT05794477) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2023-04-28 |
| The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease (NCT05759208) | Okyo Pharma Ltd | 2023-04-28 |
| Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free) (NCT05835245) | Fudan University | 2023-04-28 |
| AD816 Crossover Study (NCT05793684) | Apnimed | 2023-04-28 |
| Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD) (NCT06127225) | Dexa Medica Group | 2023-04-28 |
| A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression (NCT05736731) | A2 Biotherapeutics Inc. | 2023-04-28 |
| A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers (NCT05789485) | Memorial Sloan Kettering Cancer Center | 2023-04-28 |
| CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT (NCT05943067) | University Hospital Tuebingen | 2023-04-27 |
| APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion (NCT04919629) | Roswell Park Cancer Institute | 2023-04-27 |
| A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer (NCT05742750) | Sun Yat-sen University | 2023-04-27 |
| Nimotuzumab Plus AG in Pancreatic Cancer With Liver Metastasis (NCT06405685) | Tianjin Medical University Cancer Institute and Hospital | 2023-04-27 |
| A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze) (NCT05894083) | University of Michigan Rogel Cancer Center | 2023-04-27 |
| Dapiglutide for the Treatment of Obesity (NCT05788601) | University Hospital, Gentofte, Copenhagen | 2023-04-27 |
| Assessing the Effect of a Mineral-enriched Powder on Iron Deficiency in Women of Reproductive Age (NCT05990166) | Carleton University | 2023-04-27 |
| Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients (NCT06370065) | Tianjin Medical University Cancer Institute and Hospital | 2023-04-27 |
| Altering Default Mode Network Activity With Transcranial Focused Ultrasound to Reduce Depressive Symptoms (NCT06320028) | University of Arizona | 2023-04-27 |
| Viral Mucosal Reprogramming (NCT05331170) | The University of Texas Medical Branch, Galveston | 2023-04-27 |
| Pilot Study of Ketamine Sedation for Aneurysmal Subarachnoid Hemorrhage (NCT05032118) | Jenna L Leclerc MD, PhD | 2023-04-27 |
| OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients (NCT07406217) | Calmy Alexandra | 2023-04-27 |
| TATE and KN046 in MCRC (NCT06834399) | Zhejiang Raygene Pharmaceuticals Co., Ltd | 2023-04-27 |
| Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer (NCT05779943) | Emory University | 2023-04-27 |
| A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With Linaclotide (NCT05760313) | AbbVie | 2023-04-27 |
| OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial (NCT05587894) | ANRS, Emerging Infectious Diseases | 2023-04-27 |
| A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (NCT05823974) | GlaxoSmithKline | 2023-04-27 |
| An Early Phase 2 Clinical Study of KSP-0243 (NCT05831670) | Kissei Pharmaceutical Co., Ltd. | 2023-04-27 |
| A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT06087289) | Novakand Pharma AB | 2023-04-26 |
| Safety and Effectiveness of Trappa Ethanolamine Tablets Combined With Ciclosporin in the Treatment of Primary Treatment of Non-severe Aplastic Anemia (NCT05797623) | Jiangsu HengRui Medicine Co., Ltd. | 2023-04-26 |
| Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis. (NCT05814939) | Jiangsu vcare pharmaceutical technology co., LTD | 2023-04-26 |
| Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN) (NCT05540665) | Amgen | 2023-04-26 |
| Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial (NCT05664789) | Stanford University | 2023-04-26 |
| Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy (NCT05781308) | Intergroupe Francophone de Cancerologie Thoracique | 2023-04-26 |
| Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy (NCT05753462) | Sqy Therapeutics | 2023-04-26 |
| FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma (NCT05466799) | OncoSil Medical Limited | 2023-04-26 |
| Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD） (NCT05795517) | Haisco Pharmaceutical Group Co., Ltd. | 2023-04-26 |
| Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing (NCT05560477) | University of Cincinnati | 2023-04-26 |
| Evaluation of GeranylGeranylAcetone in Heart Failure With Preserved Ejection Fraction (NCT05672134) | Amsterdam UMC, location VUmc | 2023-04-26 |
| Body Weight Adjusted Clopidogrel Treatment in Patients With CORonary Artery Disease (NCT05657041) | St. Antonius Hospital | 2023-04-26 |
| Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC) (NCT05770882) | Great Novel Therapeutics Biotech & Medicals Corporation | 2023-04-25 |
| Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer (NCT05963490) | Fudan University | 2023-04-25 |
| A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes (NCT05732103) | Chordia Therapeutics, Inc. | 2023-04-25 |
| To Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B (NCT05760781) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2023-04-25 |
| Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus (NCT05268237) | Biolingus | 2023-04-25 |
| Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B (NCT05760703) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2023-04-25 |
| Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial (NCT05554328) | National Cancer Institute (NCI) | 2023-04-25 |
| A Study of GFH925 in Combination With Cetuximab in Previously Untreated Advanced NSCLC Harboring KRAS G12C Mutation (NCT05756153) | Genfleet Therapeutics (Shanghai) Inc. | 2023-04-25 |
| Rural Libraries Promoting Walking and Walkability in Their Rural Communities (NCT05677906) | Oregon Health and Science University | 2023-04-25 |
| IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors (NCT05991518) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2023-04-25 |
| Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study (NCT05019703) | M.D. Anderson Cancer Center | 2023-04-25 |
| Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer (NCT05775159) | AstraZeneca | 2023-04-24 |
| Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease (NCT05599347) | Rambam Health Care Campus | 2023-04-24 |
| Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis (NCT05785715) | AbbVie | 2023-04-24 |
| Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC（AK104-IIT-13） (NCT05794750) | JIN JING | 2023-04-24 |
| Efficacy and Safety of corticoSTEROids Added to Standard Therapy in Patients With Acute Heart Failure (STERO-AHF) (NCT05809011) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2023-04-24 |
| Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ) (NCT05269160) | Baylor College of Medicine | 2023-04-24 |
| Altropane Dose for Imaging Patients With Suspected Parkinson's Disease (NCT05636852) | GE Healthcare | 2023-04-24 |
| Phase 2 Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AZ-3102 in Patients With GM2 Gangliosidosis or Niemann-Pick Type C Disease (NCT05758922) | Azafaros B.V. | 2023-04-24 |